Insider Shareholders with Direct Ownership of Immunovant, Inc. (IMVT)
This section provides a comprehensive overview of the insiders with direct ownership of Immunovant, Inc. (IMVT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Immunovant, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 40,282,953 | 0 | 96,650,341 $2.66 Billion | 4 |
Jan 13, 2025
Added 14.84%
|
|
|
Peter Salzmann
Chief Executive Officer |
1,824,563 | 609,957 | 1,214,606 $33.4 Million | 37 |
Apr 01, 2025
Added 17.96%
|
|
Frank Torti
Director |
806,639 | 0 | 835,039 $23 Million | 7 |
Apr 01, 2025
Added 19.27%
|
|
Julia G. Butchko
Chief Development Officer |
607,788 | 171,829 | 440,959 $12.1 Million | 28 |
Aug 21, 2024
Reduced 0.03%
|
|
Eva Renee Barnett
Chief Financial Officer |
546,836 | 136,006 | 410,830 $11.3 Million | 28 |
Apr 01, 2025
Added 17.79%
|
|
William L. Macias
Chief Medical Officer |
479,611 | 122,258 | 357,353 $9.83 Million | 26 |
Feb 19, 2025
Reduced 0.57%
|
|
Mark S. Levine
Chief Legal Officer |
398,458 | 79,230 | 319,228 $8.78 Million | 21 |
Nov 20, 2024
Reduced 1.13%
|
|
Michael Geffner
Chief Medical Officer |
156,552 | 22,664 | 233,888 $6.43 Million | 7 |
Apr 01, 2025
Added 30.28%
|
|
Jay S Stout
Chief Technology Officer |
231,159 | 14,987 | 216,172 $5.95 Million | 7 |
Apr 01, 2025
Added 26.06%
|
|
Melanie Gloria
Chief Operating Officer |
186,137 | 0 | 186,137 $5.12 Million | 2 |
Apr 01, 2025
Added 29.04%
|
|
Christopher Van Tuyl
Chief Legal Officer |
160,743 | 0 | 160,743 $4.42 Million | 2 |
Apr 01, 2025
Added 24.01%
|
|
George V Migausky
Director |
105,251 | 12,700 | 137,251 $3.78 Million | 8 |
Apr 01, 2025
Added 10.55%
|
|
Douglas J. Hughes
Director |
116,498 | 5,425 | 135,773 $3.74 Million | 8 |
Apr 01, 2025
Added 10.65%
|
|
Rita Jain
Chief Medical Officer |
129,365 | 0 | 129,365 $3.56 Million | 2 |
Mar 19, 2021
Added 45.81%
|
|
Andrew J. Fromkin
Director |
103,751 | 20,350 | 108,101 $2.97 Million | 9 |
Apr 01, 2025
Added 13.02%
|
|
Atul Pande
Director |
98,251 | 20,100 | 102,851 $2.83 Million | 8 |
Apr 01, 2025
Added 13.6%
|
|
Michael James Elliott
Chief Scientific Officer |
97,600 | 0 | 97,600 $2.68 Million | 1 |
Mar 19, 2021
Added 50.0%
|
|
Connealy Pamela Yanchik
Chief Financial Officer |
46,200 | 0 | 46,200 $1.27 Million | 1 |
Mar 19, 2021
Added 50.0%
|